607
Views
166
CrossRef citations to date
0
Altmetric
Research Article

ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES

, , , , , , , , , , , , & show all
Pages 165-172 | Published online: 15 Jul 2002

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (17)

Yu. A. Tereshkina, T. I. Torkhovskaya, E. G. Tikhonova, L. V. Kostryukova, M. A. Sanzhakov, E. I. Korotkevich, Yu. Yu. Khudoklinova, N. A. Orlova & E. F. Kolesanova. (2022) Nanoliposomes as drug delivery systems: safety concerns. Journal of Drug Targeting 30:3, pages 313-325.
Read now
Amit Alexander, Mukta Agrawal, Ajaz Uddin, Sabahuddin Siddique, Ahmed M Shehata, Mahmoud A Shaker, Syed Ata Ur Rahman, Mohi Iqbal M Abdul & Mohamed A Shaker. (2019) Recent expansions of novel strategies towards the drug targeting into the brain. International Journal of Nanomedicine 14, pages 5895-5909.
Read now
V Escamilla-Rivera, A Solorio-Rodríguez, M Uribe-Ramírez, O Lozano, S Lucas, A Chagolla-López, R Winkler & A De Vizcaya-Ruiz. (2019) Plasma protein adsorption on Fe3O4-PEG nanoparticles activates the complement system and induces an inflammatory response. International Journal of Nanomedicine 14, pages 2055-2067.
Read now
Keren Turjeman & Yechezkel Barenholz. (2016) Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases. Journal of Drug Targeting 24:9, pages 805-820.
Read now
Renu Agarwal, Igor Iezhitsa, Puneet Agarwal, Nurul Alimah Abdul Nasir, Norhafiza Razali, Renad Alyautdin & Nafeeza Mohd Ismail. (2016) Liposomes in topical ophthalmic drug delivery: an update. Drug Delivery 23:4, pages 1075-1091.
Read now
Tarun Garg, Saurav Bhandari, Goutam Rath & Amit K. Goyal. (2015) Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor. Journal of Drug Targeting 23:10, pages 865-887.
Read now
Feifei Li, Yuxia Luan, Xiaoli Liu, Jianmei Pang, Guimei Lin, Wei Shao & Zhonghao Li. (2011) Characterization and Aggregation Behaviors of Mixed DDAB/SDS Solution With and Without Poly(4-styrenesulfonic Acid-Co-Maleic Acid) Sodium. Journal of Dispersion Science and Technology 32:11, pages 1624-1633.
Read now
Thomas Kaasgaard & Thomas L Andresen. (2010) Liposomal cancer therapy: exploiting tumor characteristics. Expert Opinion on Drug Delivery 7:2, pages 225-243.
Read now
Peter L. E. M. van Lent, Gerard C. Krijger, Wouter Hofkens, Victor A. Nievaart, Annet W. Sloetjes, Ray L. Moss, Gerben A. Koning & Wim B. van den Berg. (2009) Selectively induced death of macrophages in the synovial lining of murine knee joints using 10B-liposomes and boron neutron capture synovectomy. International Journal of Radiation Biology 85:10, pages 860-871.
Read now
Ingo H Tarner & Ulf Müller-Ladner. (2008) Drug delivery systems for the treatment of rheumatoid arthritis. Expert Opinion on Drug Delivery 5:9, pages 1027-1037.
Read now
Beth A Goins. (2008) Radiolabeled lipid nanoparticles for diagnostic imaging. Expert Opinion on Medical Diagnostics 2:7, pages 853-873.
Read now
Stavroula Sofou & George Sgouros. (2008) Antibody-targeted liposomes in cancer therapy and imaging. Expert Opinion on Drug Delivery 5:2, pages 189-204.
Read now
Vildete A. S. Carmo, Mônica C. De Oliveira, Eduardo C. O. Reis, Tânia M. P. D. Guimarães, José M. C. Vilela, Margareth S. Andrade, Marilene S. M. Michalick & Valbert N. Cardoso. (2008) Physicochemical Characterization and Study of in vitro Interactions of pH-sensitive Liposomes with the Complement System. Journal of Liposome Research 18:1, pages 59-70.
Read now
S. Moein Moghimi, Islam Hamad, Rolf Bünger, Thomas L. Andresen, Kent Jørgensen, A. Christy Hunter, Lajos Baranji, Laszlo Rosivall & Janos Szebeni. (2006) Activation of the Human Complement System by Cholesterol-Rich and PEGylated Liposomes—Modulation of Cholesterol-Rich Liposome-Mediated Complement Activation by Elevated Serum LDL and HDL Levels. Journal of Liposome Research 16:3, pages 167-174.
Read now
Xuedong Yan, Gerrit L. Scherphof & Jan A. A. M. Kamps. (2005) Liposome Opsonization. Journal of Liposome Research 15:1-2, pages 109-139.
Read now
Michael Bodo, Janos Szebeni, Lajos Baranyi, Sandor Savay, Frederick J. Pearce, Carl R. Alving & Rolf Bünger. (2005) Cerebrovascular Involvement in Liposome—Induced Cardiopulmonary Distress in Pigs. Journal of Liposome Research 15:1-2, pages 3-14.
Read now
. (2003) Literature Alerts. Journal of Microencapsulation 20:2, pages 279-287.
Read now

Articles from other publishers (149)

Sadia Rafique, Farah Sattar, Amina` Habib, Saif`` Babar, Abdul Qader, Mariam Davis, Sana`` Javed`, Muhammad Usama Ibrahim Khan, Muhammad Haris, Hamza Tariq & . Afnan. (2023) Gel Formulation and an In-vitro Kinetic Permeation Release Study of Cefixime Trihydrate and Chlorpheniramine Maleate (CCM). Pakistan Journal of Health Sciences, pages 109-114.
Crossref
Yi-fei Yu, Er-can Wu, Shi-qi Lin, Yu-xiu Chu, Yang Yang, Feng Pan, Tian-hao Ding, Jun Qian, Kuan Jiang & Chang-you Zhan. (2023) Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin. Acta Pharmacologica Sinica.
Crossref
Noriyuki Kasagi, Issei Doi, Jun Nakabayashi, Kengo Saito, Akiko Tadakuma, Nanae Muraki, Ritsuko Hori, Toshifumi Kimura, Ken Okada, Naoki Yamada, Keiko Makita-Suzuki, Hiroki Tanisaka, Susumu Shimoyama & Mikinaga Mori. (2023) Optimization of dihydrosphingomyelin/cholesterol mol ratio in topotecan-loaded liposomes to enhance drug retention and plasma half-life by understanding physicochemical and thermodynamic properties of the lipid membrane. Journal of Molecular Structure 1283, pages 135333.
Crossref
Kirsten Pondman, Séverine Le Gac & Uday Kishore. (2023) Nanoparticle-induced immune response: Health risk versus treatment opportunity?. Immunobiology 228:2, pages 152317.
Crossref
Richard d’Arcy, Farah El MohtadiNora Francini, Carlisle R. DeJulius, Hyunmoon Back, Arianna Gennari, Mike Geven, Maria Lopez-Cavestany, Zulfiye Yesim TurhanFang Yu, Jong Bong Lee, Michael R. King, Leonid Kagan, Craig L. Duvall & Nicola Tirelli. (2022) A Reactive Oxygen Species-Scavenging ‘Stealth’ Polymer, Poly(thioglycidyl glycerol), Outperforms Poly(ethylene glycol) in Protein Conjugates and Nanocarriers and Enhances Protein Stability to Environmental and Biological Stressors. Journal of the American Chemical Society 144:46, pages 21304-21317.
Crossref
Jiayin Han, Chen Pan, Xuan Tang, Qi Li, Yan Zhu, Yushi Zhang & Aihua Liang. (2022) Hypersensitivity reactions to small molecule drugs. Frontiers in Immunology 13.
Crossref
Jessica A. Mills, Feifei Liu, Thomas R. Jarrett, Nicholas L. Fletcher & Kristofer J. Thurecht. (2022) Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation. Biomaterials Science 10:12, pages 3029-3053.
Crossref
Jiho Kim, Chang Li, Hongjie Wang, Swarnendu Kaviraj, Sanjay Singh, Laxman Savergave, Arjun Raghuwanshi, Sucheol Gil, Audrey Germond, Audrey Baldessari, Bingmae Chen, Steve Roffler, Pascal Fender, Charles Drescher, Darrick Carter & André Lieber. (2022) Translational development of a tumor junction opening technology. Scientific Reports 12:1.
Crossref
Min Liu, Jie Li, Dan Zhao, Na Yan, Hongxia Zhang, Mengyang Liu, Xueying Tang, Yawei Hu, Junqiang Ding, Ning Zhang, Xinrong Liu, Yihui Deng, Yanzhi Song & Xiuli Zhao. (2022) Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy. Biomaterials 283, pages 121415.
Crossref
Rasmus Münter, Camilla Stavnsbjerg, Esben Christensen, Mikkel E. Thomsen, Allan Stensballe, Anders E. Hansen, Ladan Parhamifar, Kasper Kristensen, Jens B. Simonsen, Jannik B. Larsen & Thomas L. Andresen. (2022) Unravelling Heterogeneities in Complement and Antibody Opsonization of Individual Liposomes as a Function of Surface Architecture. Small 18:14, pages 2106529.
Crossref
Chi Zhang, Yifan Ma, Jingjing Zhang, Jimmy Chun-Tien Kuo, Zhongkun Zhang, Haotian Xie, Jing Zhu & Tongzheng Liu. (2022) Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy. Molecules 27:6, pages 1943.
Crossref
Swati Sharma, Roza Parveen & Biswa Prasun Chatterji. (2021) Toxicology of Nanoparticles in Drug Delivery. Current Pathobiology Reports 9:4, pages 133-144.
Crossref
M.A. Sanzhakov, V.A. Kudinov, K.K. Baskaev, G.E. Morozevich, D.S. Stepanova, T.I. Torkhovskaya, Yu. A. Tereshkina, E.I. Korotkevich & E.G. Tikhonova. (2021) Composite phospholipid-gold nanoparticles with targeted fragment for tumor imaging. Biomedicine & Pharmacotherapy 142, pages 111985.
Crossref
Sarah Le Saux, Anne Aubert-Pouëssel, Khaled Elhady Mohamed, Pierre Martineau, Laurence Guglielmi, Jean-Marie Devoisselle, Philippe Legrand, Joël Chopineau & Marie Morille. (2021) Interest of extracellular vesicles in regards to lipid nanoparticle based systems for intracellular protein delivery. Advanced Drug Delivery Reviews 176, pages 113837.
Crossref
Nur Najihah Izzati Mat Rani, Zahraa Mustafa Hussein, Fahimi Mustapa, Hanisah Azhari, Mahendran Sekar, Xiang Yi Chen & Mohd Cairul Iqbal Mohd Amin. (2021) Exploring the possible targeting strategies of liposomes against methicillin-resistant Staphylococcus aureus (MRSA). European Journal of Pharmaceutics and Biopharmaceutics 165, pages 84-105.
Crossref
Mariya Pykhtina, Svetlana Miroshnichenko, Vladimir Romanov, Antonina Grazhdantseva, Galina Kochneva & Anatoly Beklemishev. (2021) Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity. Pharmaceuticals 14:5, pages 459.
Crossref
Man-fei Yi, Liang-jian Chen, Hui-li He, Lei Shi, Chun-sheng Shao & Bo Zhang. (2021) Effects of grafting cell penetrate peptide and RGD on endocytosis and biological effects of Mg-CaPNPs-CKIP-1 siRNA carrier system in vitro接枝 TAT 和 RGD 对 Mg-CaPNPs-CKIP-1 siRNA 载体系统的体外胞吞和生物学效应的影响. Journal of Central South University 28:5, pages 1291-1304.
Crossref
Vincenzo De Leo, Francesco Milano, Angela Agostiano & Lucia Catucci. (2021) Recent Advancements in Polymer/Liposome Assembly for Drug Delivery: From Surface Modifications to Hybrid Vesicles. Polymers 13:7, pages 1027.
Crossref
Ninh M. La-Beck, Md. Rakibul Islam & Maciej M. Markiewski. (2021) Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine. Frontiers in Immunology 11.
Crossref
Shoba Narayan. 2021. Nanomedicine for Cancer Diagnosis and Therapy. Nanomedicine for Cancer Diagnosis and Therapy 221 249 .
Rachael M. Crist, Siva Sai Krishna Dasa, Christina H. Liu, Jeffrey D. Clogston, Marina A. Dobrovolskaia & Stephan T. Stern. (2020) Challenges in the development of nanoparticle‐based imaging agents: Characterization and biology. WIREs Nanomedicine and Nanobiotechnology 13:1.
Crossref
Neelam Thakur, Saloni Thakur, Sharmistha Chatterjee, Joydeep Das & Parames C. Sil. (2020) Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy. Frontiers in Chemistry 8.
Crossref
Alex Bunker & Tomasz Róg. (2020) Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery. Frontiers in Molecular Biosciences 7.
Crossref
Praveesh Valissery, Roshni Thapa, Jyoti Singh, Deepak Gaur, Jaydeep Bhattacharya, Agam Prasad Singh & Suman Kumar Dhar. (2020) Potent in vivo antimalarial activity of water-soluble artemisinin nano-preparations . RSC Advances 10:59, pages 36201-36211.
Crossref
Valentina Francia, Raymond M. Schiffelers, Pieter R. Cullis & Dominik Witzigmann. (2020) The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy. Bioconjugate Chemistry 31:9, pages 2046-2059.
Crossref
Xiangsheng Liu, Ivanna Tang, Zev A. Wainberg & Huan Meng. (2020) Safety Considerations of Cancer Nanomedicine—A Key Step toward Translation. Small 16:36, pages 2000673.
Crossref
Sruti Bheri, Jessica R Hoffman, Hyun-Ji Park & Michael E Davis. (2020) Biomimetic nanovesicle design for cardiac tissue repair. Nanomedicine 15:19, pages 1873-1896.
Crossref
Yuzhu Wang, Junjie Li, Indhumathy Subramaniyan, Goncalo Dias do Vale, Jaideep Chaudhary, Arnida Anwar, Mary Wight-Carter, Jeffrey G. McDonald, William C. Putnam, Tao Qin, Hongwei Zhang & Ian R. Corbin. (2020) An implanted port-catheter system for repeated hepatic arterial infusion of low-density lipoprotein-docosahexaenoic acid nanoparticles in normal rats: A safety study. Toxicology and Applied Pharmacology 400, pages 115037.
Crossref
Alberto Gabizon & Janos Szebeni. (2020) Complement Activation: A Potential Threat on the Safety of Poly(ethylene glycol)-Coated Nanomedicines. ACS Nano 14:7, pages 7682-7688.
Crossref
Hisako Ibaraki, Takanori Kanazawa, Wan-Yi Chien, Hidemasa Nakaminami, Masakazu Aoki, Kosuke Ozawa, Hiroshi Kaneko, Yuuki Takashima, Norihisa Noguchi & Yasuo Seta. (2020) The effects of surface properties of liposomes on their activity against Pseudomonas aeruginosa PAO-1 biofilm. Journal of Drug Delivery Science and Technology 57, pages 101754.
Crossref
Huan Li, Tao Huang, Yanhong Wang, Baolong Pan, Ling Zhang, Qinli Zhang & Qiao Niu. (2020) Toxicity of alumina nanoparticles in the immune system of mice. Nanomedicine 15:9, pages 927-946.
Crossref
Nicola d'Avanzo, Christian Celia, Antonella Barone, Maria Carafa, Luisa Di Marzio, Hélder A. Santos & Massimo Fresta. (2020) Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach. Advanced Therapeutics 3:3, pages 1900170.
Crossref
Collin T. Inglut, Aaron J. Sorrin, Thilinie Kuruppu, Shruti Vig, Julia Cicalo, Haroon Ahmad & Huang-Chiao Huang. (2020) Immunological and Toxicological Considerations for the Design of Liposomes. Nanomaterials 10:2, pages 190.
Crossref
Carly F. Chisholm, William Behnke, Yekaterina Pokhilchuk, Ashley A. Frazer-Abel & Theodore W. Randolph. (2020) Subvisible Particles in IVIg Formulations Activate Complement in Human Serum. Journal of Pharmaceutical Sciences 109:1, pages 558-565.
Crossref
Oliver S. Thomas & Wilfried Weber. (2019) Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Stefan Bleher, Jonas Buck, Christian Muhl, Sandro Sieber, Sabine Barnert, Dominik Witzigmann, Jörg Huwyler, Matthias Barz & Regine Süss. (2019) Poly(Sarcosine) Surface Modification Imparts Stealth‐Like Properties to Liposomes. Small 15:50, pages 1904716.
Crossref
Seyed Mohammad Gheibi Hayat, Vanessa Bianconi, Matteo Pirro & Amirhossein Sahebkar. (2019) Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry. International Journal of Pharmaceutics 569, pages 118628.
Crossref
Rosario Mare, Huining Da, Massimo Fresta, Donato Cosco & Vibhudutta Awasthi. (2019) Anchoring Property of a Novel Hydrophilic Lipopolymer, HDAS-SHP, Post-Inserted in Preformed Liposomes. Nanomaterials 9:9, pages 1185.
Crossref
Fahimeh Zahednezhad, Maryam Saadat, Hadi Valizadeh, Parvin Zakeri-Milani & Behzad Baradaran. (2019) Liposome and immune system interplay: Challenges and potentials. Journal of Controlled Release 305, pages 194-209.
Crossref
Haley R. Phillips, Zachary P. Tolstyka, Bryan C. Hall, Joseph K. Hexum, Perry B. Hackett & Theresa M. Reineke. (2019) Glycopolycation–DNA Polyplex Formulation N/P Ratio Affects Stability, Hemocompatibility, and in Vivo Biodistribution. Biomacromolecules 20:4, pages 1530-1544.
Crossref
Ninh M. La-Beck, Xinli Liu & Laurence M. Wood. (2019) Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery. Frontiers in Pharmacology 10.
Crossref
Xiaoyi Wang, Huan Wang, Kuan Jiang, Yanyu Zhang, Changyou Zhan, Man Ying, Mingfei Zhang, Linwei Lu, Ruifeng Wang, Songli Wang, Diane J. Burgess, Hao Wang & Weiyue Lu. (2019) Liposomes with cyclic RGD peptide motif triggers acute immune response in mice. Journal of Controlled Release 293, pages 201-214.
Crossref
Alexander J. Donovan & Ying Liu. 2019. Nanotheranostics for Cancer Applications. Nanotheranostics for Cancer Applications 207 229 .
Betina Børresen, Jonas R. Henriksen, Gael Clergeaud, Jennifer S. Jørgensen, Fredrik Melander, Dennis R. Elema, Janos Szebeni, Svend Aage Engelholm, Annemarie T. Kristensen, Andreas Kjær, Thomas L. Andresen & Anders E. Hansen. (2018) Theranostic Imaging May Vaccinate against the Therapeutic Benefit of Long Circulating PEGylated Liposomes and Change Cargo Pharmacokinetics. ACS Nano 12:11, pages 11386-11398.
Crossref
Sean D. Allen, Yu-Gang Liu, Sharan Bobbala, Lei Cai, Peter I. Hecker, Ryan Temel & Evan A. Scott. (2018) Polymersomes scalably fabricated via flash nanoprecipitation are non-toxic in non-human primates and associate with leukocytes in the spleen and kidney following intravenous administration. Nano Research 11:10, pages 5689-5703.
Crossref
Barry Neun, Yechezkel Barenholz, Janos Szebeni & Marina Dobrovolskaia. (2018) Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro. Molecules 23:7, pages 1700.
Crossref
Denisa Lizoňová, Monika Majerská, Vlastimil Král, Michal Pechar, Robert Pola, Marek Kovář & František Štěpánek. (2018) Antibody-pHPMA functionalised fluorescent silica nanoparticles for colorectal carcinoma targeting. RSC Advances 8:39, pages 21679-21689.
Crossref
Tamás Fülöp, Réka Nemes, Tamás Mészáros, Rudolf Urbanics, Robbert Jan Kok, Joshua A. Jackman, Nam-Joon Cho, Gert Storm & János Szebeni. (2018) Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information. Journal of Controlled Release 270, pages 268-274.
Crossref
Barry W. Neun, Anna N. Ilinskaya & Marina A. Dobrovolskaia. 2018. Characterization of Nanoparticles Intended for Drug Delivery. Characterization of Nanoparticles Intended for Drug Delivery 149 160 .
Anna Maria Grimaldi, Mariarosaria Incoronato, Marco Salvatore & Andrea Soricelli. (2017) Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics. Nanomedicine 12:19, pages 2349-2365.
Crossref
Loujin Houdaihed, James C. Evans & Christine Allen. (2017) Overcoming the Road Blocks: Advancement of Block Copolymer Micelles for Cancer Therapy in the Clinic. Molecular Pharmaceutics 14:8, pages 2503-2517.
Crossref
Jennifer L. MarloweVioletta AkopianPriya KarmaliDouglas KornbrustJennifer LockridgeSean Semple. (2017) Recommendations of the Oligonucleotide Safety Working Group's Formulated Oligonucleotide Subcommittee for the Safety Assessment of Formulated Oligonucleotide-Based Therapeutics. Nucleic Acid Therapeutics 27:4, pages 183-196.
Crossref
Ninh M. La-Beck & Alberto A. Gabizon. (2017) Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy. Frontiers in Immunology 8.
Crossref
Shoshy Mizrahy, Inbal Hazan-Halevy, Dalit Landesman-Milo, Brandon D. Ng & Dan Peer. (2017) Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles. Frontiers in Immunology 8.
Crossref
Jean Cornier, Andrew Owen, Arno Kwade & Marcel Van de VoordeKeren Turjeman & Yechezkel Barenholz. 2017. Pharmaceutical Nanotechnology: Innovation and Production. Pharmaceutical Nanotechnology: Innovation and Production 603 632 .
Tamás Gyula Fülöp, Josbert M. Metselaar, Gert Storm & János Szebeni. (2017) The role of thromboxane A2 in complement activation-related pseudoallergy. European Journal of Nanomedicine 9:2.
Crossref
Elena Montes-Cobos, Sarah Ring, Henrike J. Fischer, Joachim Heck, Judith Strauß, Markus Schwaninger, Sybille D. Reichardt, Claus Feldmann, Fred Lühder & Holger M. Reichardt. (2017) Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles. Journal of Controlled Release 245, pages 157-169.
Crossref
G.M. Mortimer & R.F. Minchin. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development 373 392 .
Alberto A. Gabizon, Yogita Patil & Ninh M. La-Beck. (2016) New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy. Drug Resistance Updates 29, pages 90-106.
Crossref
Alex Bunker, Aniket Magarkar & Tapani Viitala. (2016) Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their PEGylation. Biochimica et Biophysica Acta (BBA) - Biomembranes 1858:10, pages 2334-2352.
Crossref
Phatsapong Yingchoncharoen, Danuta S. Kalinowski & Des R. Richardson. (2016) Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Pharmacological Reviews 68:3, pages 701-787.
Crossref
J. WhritenourS. CasinghinoM. CollingeX. Zhu. (2016) Nonclinical Tools to Assess Risk of Drug Hypersensitivity Reactions. Annual Review of Pharmacology and Toxicology 56:1, pages 561-576.
Crossref
D. Sprouse, T.M. Reineke & M.E. Davis. 2016. Reference Module in Materials Science and Materials Engineering. Reference Module in Materials Science and Materials Engineering.
Janos Szebeni & Gert Storm. (2015) Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs. Biochemical and Biophysical Research Communications 468:3, pages 490-497.
Crossref
Heather Herd Gustafson, Dolly Holt-Casper, David W. Grainger & Hamidreza Ghandehari. (2015) Nanoparticle uptake: The phagocyte problem. Nano Today 10:4, pages 487-510.
Crossref
Munehira Kawanishi, Yosuke Hashimoto, Taro Shimizu, Ikuko Sagawa, Tatsuhiro Ishida & Hiroshi Kiwada. (2015) Comprehensive analysis of PEGylated liposome-associated proteins relating to the accelerated blood clearance phenomenon by combination with shotgun analysis and conventional methods. Biotechnology and Applied Biochemistry 62:4, pages 547-555.
Crossref
Alex Bunker. 2015. Computational Pharmaceutics. Computational Pharmaceutics 217 233 .
Lu Xu, Lei Feng, Jingcheng Hao & Shuli Dong. (2015) Controlling the Capture and Release of DNA with a Dual-Responsive Cationic Surfactant. ACS Applied Materials & Interfaces 7:16, pages 8876-8885.
Crossref
Kristina Bram Knudsen, Helle Northeved, Pramod Kumar EK, Anders Permin, Torben Gjetting, Thomas L. Andresen, Steen Larsen, Karen Malene Wegener, Jens Lykkesfeldt, Kim Jantzen, Steffen Loft, Peter Møller & Martin Roursgaard. (2015) In vivo toxicity of cationic micelles and liposomes. Nanomedicine: Nanotechnology, Biology and Medicine 11:2, pages 467-477.
Crossref
Anju Gupta, Reetu Gupta & Sudarshan Kurwardkar. 2015. Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering. Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering 301 332 .
Okhil K. Nag, Vivek R. Yadav, Brandon Croft, Andria Hedrick & Vibhudutta Awasthi. (2015) Liposomes Modified with Superhydrophilic Polymer Linked to a Nonphospholipid Anchor Exhibit Reduced Complement Activation and Enhanced Circulation. Journal of Pharmaceutical Sciences 104:1, pages 114-123.
Crossref
Calum Kinnear, David Burnand, Martin J. D. Clift, Andreas F. M. Kilbinger, Barbara Rothen-Rutishauser & Alke Petri-Fink. (2014) Polyvinylalkohol als biokompatibles Polymer zur Passivierung von Goldnanostäbchen. Angewandte Chemie 126:46, pages 12821-12825.
Crossref
Janos Szebeni. (2014) Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals. Molecular Immunology 61:2, pages 163-173.
Crossref
Vivek R. Yadav, Okhil Nag & Vibhudutta Awasthi. (2014) Biological Evaluation of Liposome-Encapsulated Hemoglobin Surface-Modified With a Novel PEGylated Nonphospholipid Amphiphile. Artificial Organs 38:8, pages 625-633.
Crossref
Calum Kinnear, David Burnand, Martin J. D. Clift, Andreas F. M. Kilbinger, Barbara Rothen-Rutishauser & Alke Petri-Fink. (2014) Polyvinyl Alcohol as a Biocompatible Alternative for the Passivation of Gold Nanorods. Angewandte Chemie International Edition, pages n/a-n/a.
Crossref
Lara K. Bogart, Genevieve Pourroy, Catherine J. Murphy, Victor Puntes, Teresa Pellegrino, Daniel Rosenblum, Dan Peer & Raphaël Lévy. (2014) Nanoparticles for Imaging, Sensing, and Therapeutic Intervention. ACS Nano 8:4, pages 3107-3122.
Crossref
Lu Xu, Jingfei Chen, Lei Feng, Shuli Dong & Jingcheng Hao. (2014) Loading capacity and interaction of DNA binding on catanionic vesicles with different cationic surfactants. Soft Matter 10:45, pages 9143-9152.
Crossref
Che-Ming J. Hu, Ronnie H. Fang, Brian T. Luk & Liangfang Zhang. (2014) Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. Nanoscale 6:1, pages 65-75.
Crossref
Okhil Nag & Vibhudutta Awasthi. (2013) Surface Engineering of Liposomes for Stealth Behavior. Pharmaceutics 5:4, pages 542-569.
Crossref
Scott EliasofDouglas LazarusChristian G. PetersRoy I. CaseRoderic O. ColeJungyeon HwangThomas SchluepJoseph Chao, James Lin, Yun Yen, Han Han, Devin T. Wiley, Jonathan E. Zuckerman & Mark E. Davis. (2013) Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle. Proceedings of the National Academy of Sciences 110:37, pages 15127-15132.
Crossref
Lu Xu, Lei Feng, Renhao Dong, Jingcheng Hao & Shuli Dong. (2013) Transfection Efficiency of DNA Enhanced by Association with Salt-Free Catanionic Vesicles. Biomacromolecules 14:8, pages 2781-2789.
Crossref
Katrin Knop, David Pretzel, Annett Urbanek, Tobias Rudolph, Daniel H. Scharf, Anja Schallon, Michael Wagner, Stephanie Schubert, Michael Kiehntopf, Axel A. Brakhage, Felix H. Schacher & Ulrich S. Schubert. (2013) Star-Shaped Drug Carriers for Doxorubicin with POEGMA and POEtOxMA Brush-like Shells: A Structural, Physical, and Biological Comparison. Biomacromolecules 14:8, pages 2536-2548.
Crossref
Jolanda M. van den Hoven, Reka Nemes, Josbert M. Metselaar, Bastiaan Nuijen, Jos H. Beijnen, Gert Storm & Janos Szebeni. (2013) Complement activation by PEGylated liposomes containing prednisolone. European Journal of Pharmaceutical Sciences 49:2, pages 265-271.
Crossref
Qihang Sun, Maciej Radosz & Youqing Shen. 2013. Functional Polymers for Nanomedicine. Functional Polymers for Nanomedicine 32 62 .
László Dézsi, Gábor Szénási, Rudolf Urbanics, László Rosivall & János Szebeni. (2013) Cardiopulmonary and hemodynamic changes in complement activation-related pseudoallergy. Health 05:06, pages 1032-1038.
Crossref
János Szebeni, Zsóka Weiszhár, Zoltán Rozsnyay, Todd Martinsky, János Kádas, József Lázár, László Takács & István Kurucz. (2013) Plasma Proteome Profiling with Monoclonal Antibody Libraries: A Pilot Biomarker Analysis for Nanomedicine-Induced Complement Activation. Advances in Nanoparticles 02:02, pages 133-144.
Crossref
Afaf El-Ansary, Sooad Al-Daihan, Abir Ben Bacha & Malak Kotb. 2013. Oxidative Stress and Nanotechnology. Oxidative Stress and Nanotechnology 47 74 .
Qihang Sun, Maciej Radosz & Youqing Shen. (2012) Challenges in design of translational nanocarriers. Journal of Controlled Release 164:2, pages 156-169.
Crossref
János Szebeni, Péter Bedőcs, Domokos Csukás, László Rosivall, Rolf Bünger & Rudolf Urbanics. (2012) A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines. Advanced Drug Delivery Reviews 64:15, pages 1706-1716.
Crossref
Dan Peer. (2012) Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles. Advanced Drug Delivery Reviews 64:15, pages 1738-1748.
Crossref
Chunlei Li, Jinna Cao, Yajuan Wang, Xi Zhao, Chenxin Deng, Na Wei, Jian Yang & JingXia Cui. (2012) Accelerated Blood Clearance of Pegylated Liposomal Topotecan: Influence of Polyethylene Glycol Grafting Density and Animal Species. Journal of Pharmaceutical Sciences 101:10, pages 3864-3876.
Crossref
Dalit Landesman-Milo & Dan Peer. (2012) Altering the immune response with lipid-based nanoparticles. Journal of Controlled Release 161:2, pages 600-608.
Crossref
Tobias Miller, Alexandra Hill, Senta Uezguen, Markus Weigandt & Achim Goepferich. (2012) Analysis of Immediate Stress Mechanisms upon Injection of Polymeric Micelles and Related Colloidal Drug Carriers: Implications on Drug Targeting. Biomacromolecules 13:6, pages 1707-1718.
Crossref
Massimo S. Fiandaca, Krystof S. Bankiewicz & Howard J. Federoff. (2012) Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications. Pharmaceuticals 5:6, pages 553-590.
Crossref
Neil Desai. (2012) Challenges in Development of Nanoparticle-Based Therapeutics. The AAPS Journal 14:2, pages 282-295.
Crossref
János Szebeni, Péter Bedőcs, Rudolf Urbanics, Rolf Bünger, László Rosivall, Miklós Tóth & Yechezkel Barenholz. (2012) Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: A porcine model. Journal of Controlled Release 160:2, pages 382-387.
Crossref
Aniket Magarkar, Esra Karakas, Michał Stepniewski, Tomasz Róg & Alex Bunker. (2012) Molecular Dynamics Simulation of PEGylated Bilayer Interacting with Salt Ions: A Model of the Liposome Surface in the Bloodstream. The Journal of Physical Chemistry B 116:14, pages 4212-4219.
Crossref
Nicholas M. Molino, Kateryna Bilotkach, Deborah A. Fraser, Dongmei Ren & Szu-Wen Wang. (2012) Complement Activation and Cell Uptake Responses Toward Polymer-Functionalized Protein Nanocapsules. Biomacromolecules 13:4, pages 974-981.
Crossref
János Szebeni, Péter Bedőcs, Zoltán Rozsnyay, Zsóka Weiszhár, Rudolf Urbanics, László Rosivall, Rivka Cohen, Olga Garbuzenko, György Báthori, Miklós Tóth, Rolf Bünger & Yechezkel Barenholz. (2012) Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. Nanomedicine: Nanotechnology, Biology and Medicine 8:2, pages 176-184.
Crossref
Federica De Persiis, Camillo La Mesa & Ramon Pons. (2012) Protein-covered silica nano-particles adsorbing onto synthetic vesicles. Soft Matter 8:5, pages 1361-1368.
Crossref
T.M. Reineke & M.E. Davis. 2012. Polymer Science: A Comprehensive Reference. Polymer Science: A Comprehensive Reference 497 527 .
B.J. Crielaard, A. Yousefi, J.P. Schillemans, C. Vermehren, K. Buyens, K. Braeckmans, T. Lammers & G. Storm. (2011) An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes. Journal of Controlled Release 156:3, pages 307-314.
Crossref
Yusuke Arima, Mitsuaki Toda & Hiroo Iwata. (2011) Surface plasmon resonance in monitoring of complement activation on biomaterials. Advanced Drug Delivery Reviews 63:12, pages 988-999.
Crossref
Olivia M. Merkel, Rudolf Urbanics, Peter Bedőcs, Zoltán Rozsnyay, László Rosivall, Miklós Toth, Thomas Kissel & Janos Szebeni. (2011) In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. Biomaterials 32:21, pages 4936-4942.
Crossref
Michał Stepniewski, Marta Pasenkiewicz-Gierula, Tomasz Róg, Reinis Danne, Adam Orlowski, Mikko Karttunen, Arto Urtti, Marjo Yliperttula, Elina Vuorimaa & Alex Bunker. (2011) Study of PEGylated Lipid Layers as a Model for PEGylated Liposome Surfaces: Molecular Dynamics Simulation and Langmuir Monolayer Studies. Langmuir 27:12, pages 7788-7798.
Crossref
Massimo S. Fiandaca, Mitchel S. Berger & Krystof S. Bankiewicz. (2011) The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology. Toxins 3:4, pages 369-397.
Crossref
Feifei Li, Yuxia Luan, Xiaoli Liu, Guiying Xu, Xiuhong Li, Xiaolong Li & Jie Wang. (2011) Investigation on the aggregation behaviors of DDAB/NaDEHP catanionic vesicles in the absence and presence of a negatively charged polyelectrolyte. Physical Chemistry Chemical Physics 13:13, pages 5897.
Crossref
Nicolas Bertrand, Céline Bouvet, Pierre Moreau & Jean-Christophe Leroux. (2010) Transmembrane pH-Gradient Liposomes To Treat Cardiovascular Drug Intoxication. ACS Nano 4:12, pages 7552-7558.
Crossref
Hu Yang. (2010) Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis. Pharmaceutical Research 27:9, pages 1759-1771.
Crossref
Katrin Knop, Richard Hoogenboom, Dagmar Fischer & Ulrich S. Schubert. (2010) Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives. Angewandte Chemie International Edition 49:36, pages 6288-6308.
Crossref
Katrin Knop, Richard Hoogenboom, Dagmar Fischer & Ulrich S. Schubert. (2010) Anwendung von Poly(ethylenglycol) beim Wirkstoff‐Transport: Vorteile, Nachteile und Alternativen. Angewandte Chemie 122:36, pages 6430-6452.
Crossref
Mauro Pagani. (2010) The Complex Clinical Picture of Presumably Allergic Side Effects to Cytostatic Drugs: Symptoms, Pathomechanism, Reexposure, and Desensitization. Medical Clinics of North America 94:4, pages 835-852.
Crossref
Banu S. ZolnikÁfrica González-FernándezNakissa SadriehMarina A. Dobrovolskaia. (2010) Minireview: Nanoparticles and the Immune System. Endocrinology 151:2, pages 458-465.
Crossref
Amy Y. Grahn, Krystof S. Bankiewicz, Millicent Dugich-Djordjevic, John R. Bringas, Piotr Hadaczek, Greg A. Johnson, Simon Eastman & Matthias Luz. (2009) Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience. Journal of Neuro-Oncology 95:2, pages 185-197.
Crossref
Maira A. Pereira, Vanessa C. F. Mosqueira, Vildete A. S. Carmo, Cristiano S. Ferrari, Eduardo C.O. Reis, Gilson A. Ramaldes & Valbert N. Cardoso. (2009) Biodistribution study and identification of inflammatory sites using nanocapsules labeled with 99mTc–HMPAO. Nuclear Medicine Communications 30:9, pages 749-755.
Crossref
Wim Jiskoot, Rianne M. F. van Schie, Myrra G. Carstens & Huub Schellekens. (2009) Immunological Risk of Injectable Drug Delivery Systems. Pharmaceutical Research 26:6, pages 1303-1314.
Crossref
Mark Bartholomä, John Valliant, Kevin P. Maresca, John Babich & Jon Zubieta. (2009) Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals. Chem. Commun.:5, pages 493-512.
Crossref
Yukiko Matsuo, Tsutomu Ishihara, Junko Ishizaki, Ken-ichi Miyamoto, Megumu Higaki & Naomi Yamashita. (2009) Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cellular Immunology 260:1, pages 33-38.
Crossref
Tatsuhiro Ishida & Hiroshi Kiwada. 2009. Safety of Nanoparticles. Safety of Nanoparticles 111 130 .
Satoru Sonoke, Toshihiro Ueda, Kae Fujiwara, Yohei Sato, Kazuchika Takagaki, Kazuko Hirabayashi, Tadaaki Ohgi & Junichi Yano. (2008) Tumor Regression in Mice by Delivery of Bcl-2 Small Interfering RNA with Pegylated Cationic Liposomes. Cancer Research 68:21, pages 8843-8851.
Crossref
Noushin Heidary, Haley Naik & Susan Burgin. (2008) Chemotherapeutic agents and the skin: An update. Journal of the American Academy of Dermatology 58:4, pages 545-570.
Crossref
Adalberto Bonincontro, Maria Falivene, Camillo La Mesa, Gianfranco Risuleo & Miriam Ruiz Peña. (2008) Dynamics of DNA Adsorption on and Release from SDS−DDAB Cat−Anionic Vesicles:  a Multitechnique Study. Langmuir 24:5, pages 1973-1978.
Crossref
Tatsuhiro ISHIDA & Hiroshi KIWADA. (2008) Accelerated Blood Clearance (ABC) Phenomenon Induced by Administration of PEGylated Liposomeポリエチレングリコール修飾リポソーム投与時に生ずる Accelerated Blood Clearance (ABC)現象. YAKUGAKU ZASSHI 128:2, pages 233-243.
Crossref
Yusuke Arima, Mitsuaki Toda & Hiroo Iwata. (2008) Complement activation on surfaces modified with ethylene glycol units. Biomaterials 29:5, pages 551-560.
Crossref
Maira Alves Pereira, Vanessa Carla Furtado Mosqueira, José Mário Carneiro Vilela, Margareth Spangler Andrade, Gilson Andrade Ramaldes & Valbert Nascimento Cardoso. (2008) PLA-PEG nanocapsules radiolabeled with 99mTechnetium-HMPAO: Release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy. European Journal of Pharmaceutical Sciences 33:1, pages 42-51.
Crossref
Yuval Avnir, Rina Ulmansky, Veronica Wasserman, Simcha Even-Chen, Maya Broyer, Yechezkel Barenholz & Yaakov Naparstek. (2008) Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: A novel approach to treating autoimmune arthritis. Arthritis & Rheumatism 58:1, pages 119-129.
Crossref
Cristianne J. Rijcken, Cor J. Snel, Raymond M. Schiffelers, Cornelus F. van Nostrum & Wim E. Hennink. (2007) Hydrolysable core-crosslinked thermosensitive polymeric micelles: Synthesis, characterisation and in vivo studies. Biomaterials 28:36, pages 5581-5593.
Crossref
Stavroula Sofou. (2007) Surface-active liposomes for targeted cancer therapy. Nanomedicine 2:5, pages 711-724.
Crossref
Marco Calabresi, Patrizia Andreozzi & Camillo La Mesa. (2007) Supra-molecular Association and Polymorphic Behaviour In Systems Containing Bile Acid Salts. Molecules 12:8, pages 1731-1754.
Crossref
Jeremy D. Heidel, Zhongping Yu, Joanna Yi-Ching Liu, Shyam M. Rele, Yongchao Liang, Ryan K. ZeidanDouglas J. Kornbrust & Mark E. Davis. (2007) Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proceedings of the National Academy of Sciences 104:14, pages 5715-5721.
Crossref
Caterina Letizia, Patrizia Andreozzi, Anita Scipioni, Camillo La Mesa, Adalberto Bonincontro & Elisabetta Spigone. (2007) Protein Binding onto Surfactant-Based Synthetic Vesicles. The Journal of Physical Chemistry B 111:4, pages 898-908.
Crossref
Liangfang Zhang, Kevin Dammann, Sung Chul Bae & Steve Granick. (2007) Ligand–receptor binding on nanoparticle-stabilized liposome surfaces. Soft Matter 3:5, pages 551-553.
Crossref
S. Moein Moghimi, Islam Hamad, Thomas L. Andresen, Kent Jørgensen, Janos Szebeni, S. Moein Moghimi, Islam Hamad, Thomas L. Andresen, Kent Jørgensen & Janos Szebeni. (2006) Methylation of the phosphate oxygen moiety of phospholipid‐methoxy(polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin production. The FASEB Journal 20:14, pages 2591-2593.
Crossref
Peter Laverman, Gert Storm, William Phillips, Ande Bao & Beth Goins. 2006. Liposome Technology, Volume II. Liposome Technology, Volume II 169 185 .
Tatsuhiro Ishida, Masako Ichihara, XinYu Wang, Kenji Yamamoto, Junji Kimura, Eiji Majima & Hiroshi Kiwada. (2006) Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. Journal of Controlled Release 112:1, pages 15-25.
Crossref
Adam Judge, Kevin McClintock, Janet R. Phelps & Ian MacLachlan. (2006) Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes. Molecular Therapy 13:2, pages 328-337.
Crossref
L. Reijnders. (2006) Cleaner nanotechnology and hazard reduction of manufactured nanoparticles. Journal of Cleaner Production 14:2, pages 124-133.
Crossref
Janos Szebeni. (2005) Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity. Toxicology 216:2-3, pages 106-121.
Crossref
Tatsuhiro Ishida, Masae Harada, Xin Yu Wang, Masako Ichihara, Kenji Irimura & Hiroshi Kiwada. (2005) Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. Journal of Controlled Release 105:3, pages 305-317.
Crossref
Clifford Gevirtz. (2005) Liposomes in Pain Management. Topics in Pain Management 20:8, pages 1-6.
Crossref
Olga Garbuzenko, Samuel Zalipsky, Masoud Qazen & Yechezkel Barenholz. (2005) Electrostatics of PEGylated Micelles and Liposomes Containing Charged and Neutral Lipopolymers. Langmuir 21:6, pages 2560-2568.
Crossref
Alexander L. Klibanov. (2004) Ligand-Carrying Gas-Filled Microbubbles:  Ultrasound Contrast Agents for Targeted Molecular Imaging. Bioconjugate Chemistry 16:1, pages 9-17.
Crossref
Thomas L. Andresen, Simon S. Jensen & Kent Jørgensen. (2005) Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Progress in Lipid Research 44:1, pages 68-97.
Crossref
Sangeeta Ray Banerjee, Kevin P. Maresca, Lynn Francesconi, John Valliant, John W. Babich & Jon Zubieta. (2005) New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design. Nuclear Medicine and Biology 32:1, pages 1-20.
Crossref
David S. Alberts, Franco M. Muggia, James Carmichael, Eric P. Winer, Mohammad Jahanzeb, Alan P. Venook, Keith M. Skubitz, Edgardo Rivera, Joseph A. Sparano, Nicholas J. Dibella, Simon J. Stewart, John J. Kavanagh & Alberto A. Gabizon. (2004) Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials. Seminars in Oncology 31, pages 53-90.
Crossref
Theresa M. AllenPieter R. Cullis. (2004) Drug Delivery Systems: Entering the Mainstream. Science 303:5665, pages 1818-1822.
Crossref
Janos Szebeni. 2004. The Complement System. The Complement System 361 396 .
S.M. Moghimi & J. Szebeni. (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Progress in Lipid Research 42:6, pages 463-478.
Crossref
A.Christy Hunter & S.Moein Moghimi. (2003) Synthetic polymers in 21st century therapeutics: the way forward ▾. Drug Discovery Today 8:4, pages 154-156.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.